MUSC Professor Daniel Lackland to Receive 2025 Population Research Prize for Hypertension and Stroke Prevention Work

By Advos

TL;DR

Dr. Daniel Lackland's award-winning research provides healthcare leaders with proven hypertension strategies that reduce stroke mortality and improve population health outcomes.

Dr. Lackland's population research analyzes data from multiple epidemiologic studies to understand hypertension disparities and develop evidence-based treatment guidelines.

This research addresses health disparities in underserved communities, contributing to significant reductions in stroke mortality and improved cardiovascular care worldwide.

A leading hypertension researcher who helped reduce U.S. stroke deaths by 75% receives top honors for his groundbreaking population health studies.

Found this article helpful?

Share it with your network and spread the knowledge!

MUSC Professor Daniel Lackland to Receive 2025 Population Research Prize for Hypertension and Stroke Prevention Work

Dr. Daniel T. Lackland, professor of epidemiology and neurology at the Medical University of South Carolina, will receive the 2025 Population Research Prize at the American Heart Association's Scientific Sessions 2025 in New Orleans. The award recognizes Dr. Lackland's decades of groundbreaking research in hypertension, stroke prevention, and addressing cardiovascular disease outcome disparities across different communities.

Dr. Lackland's work has been instrumental in documenting and understanding the dramatic decline in U.S. stroke mortality rates, which dropped from 88 to 23 per 100,000 people between 1950 and 2010. As chair of a pivotal 2013 American Heart Association scientific statement, he helped attribute this significant public health achievement to aggressive hypertension treatment strategies. His research has contributed substantially to improvements in blood pressure care over the past two decades, making cardiovascular care more effective for millions of Americans.

The importance of Dr. Lackland's research extends beyond academic recognition to real-world impact on public health policy and clinical practice. His current role as principal investigator for the Black Pooling Project represents a critical effort to understand racial disparities in cardiovascular disease and hypertension among Black Americans. This national, multi-cohort observational study combines data from nine large epidemiologic studies, providing unprecedented insights into health inequities that affect vulnerable populations.

Dr. Lackland's leadership extends to multiple major research initiatives, including chairing the Executive and Steering Committees of the long-running CARDIA study and serving as chair of the Observational Study Monitoring Board for the RURAL Study. His involvement in developing clinical guidelines, including the 2013 and 2017 hypertension guidelines, has directly influenced how healthcare providers approach blood pressure management globally. As current editor-in-chief of the World Hypertension League Newsletter and past president of the World Hypertension League, Dr. Lackland continues to drive international collaborations aimed at improving circulatory health worldwide.

The recognition of Dr. Lackland's work comes at a crucial time when cardiovascular disease remains a leading cause of death globally. His focus on population-level research and health disparities addresses fundamental challenges in achieving health equity. The Population Research Prize acknowledgment underscores the vital role that epidemiological research plays in shaping effective public health interventions and clinical guidelines that save lives.

Dr. Lackland's mentorship of dozens of graduate students and his extensive service on various boards, including his past role as volunteer regional board president of the American Heart Association, demonstrates his commitment to developing the next generation of public health leaders. His work exemplifies how sustained research efforts can translate into tangible improvements in population health outcomes, particularly for underserved communities that bear a disproportionate burden of cardiovascular disease.

Curated from NewMediaWire

blockchain registration record for this content
Advos

Advos

@advos